Human gamma interferon production by cytotoxic T lymphocytes sensitized during hepatitis A virus infection
- PMID: 2843673
- PMCID: PMC253519
- DOI: 10.1128/JVI.62.10.3756-3763.1988
Human gamma interferon production by cytotoxic T lymphocytes sensitized during hepatitis A virus infection
Abstract
The production of interferon (IFN) during a chromium-51 release assay with hepatitis A virus (HAV)-infected fibroblasts and autologous peripheral blood lymphocytes from patients with acute HAV infection was studied to determine whether IFN plays a role in immunopathogenesis of hepatitis A infection in humans. Skin fibroblasts of eight patients after acute HAV infection and from two control persons without history of current or past HAV infection were infected with HAV. Peripheral blood lymphocytes were collected at different times after the onset of icterus and tested in a chromium-51 release assay against autologous HAV-infected skin fibroblasts for their cytolytic and IFN-producing activity. The IFN produced during the assay was characterized and found to have the properties of human gamma IFN. Cytotoxicity and gamma IFN release were virus specific. The cell types responsible for both functions were characterized and found to be in the HLA-dependent T8+ lymphocyte subset. Considering that gamma IFN has an antiviral effect on persistent HAV infection in vitro and that it probably accounts for stimulation of HLA class I antigen expression on hepatocytes, our experimental results presented here demonstrate that human gamma IFN produced by HAV-specific T cells may participate in pathogenesis of hepatitis A infection in humans.
Similar articles
-
Cell-mediated cytotoxicity in hepatitis A virus infection.Hepatology. 1986 Nov-Dec;6(6):1308-14. doi: 10.1002/hep.1840060614. Hepatology. 1986. PMID: 3025069
-
Suppression of hepatitis B virus replication mediated by hepatitis A-induced cytokine production.Liver. 2001 Feb;21(1):45-9. doi: 10.1034/j.1600-0676.2001.210107.x. Liver. 2001. PMID: 11169072
-
Liver-derived cytotoxic T cells in hepatitis A virus infection.J Infect Dis. 1989 Aug;160(2):209-17. doi: 10.1093/infdis/160.2.209. J Infect Dis. 1989. PMID: 2503564
-
A virological perspective on the need for vaccination.J Viral Hepat. 2000 May;7 Suppl 1:5-6. doi: 10.1046/j.1365-2893.2000.00020.x. J Viral Hepat. 2000. PMID: 10866836 Review.
-
[Specific and non-specific host defense system against hepatitis A virus (HAV) and mechanism of HAV infection].Nihon Rinsho. 2004 Aug;62 Suppl 8:438-47. Nihon Rinsho. 2004. PMID: 15453362 Review. Japanese. No abstract available.
Cited by
-
Comparison of the Clinical Features of Hepatitis A between HBsAg-Positive and HBsAg-Negative Patients.Gut Liver. 2011 Dec;5(4):500-5. doi: 10.5009/gnl.2011.5.4.500. Epub 2011 Nov 21. Gut Liver. 2011. PMID: 22195250 Free PMC article.
-
Immunity to viruses.Curr Opin Immunol. 1989-1990 Feb;2(3):347-52. doi: 10.1016/0952-7915(89)90140-4. Curr Opin Immunol. 1989. PMID: 2483882 Free PMC article. Review. No abstract available.
-
Natural History, Clinical Manifestations, and Pathogenesis of Hepatitis A.Cold Spring Harb Perspect Med. 2018 Sep 4;8(9):a031708. doi: 10.1101/cshperspect.a031708. Cold Spring Harb Perspect Med. 2018. PMID: 29440324 Free PMC article. Review.
-
Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis.Int J Mol Sci. 2017 Jul 13;18(7):1517. doi: 10.3390/ijms18071517. Int J Mol Sci. 2017. PMID: 28703774 Free PMC article. Review.
-
Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon.J Virol. 2005 Sep;79(17):10968-77. doi: 10.1128/JVI.79.17.10968-10977.2005. J Virol. 2005. PMID: 16103148 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous